SATB2 and clear cell adenocarcinoma: They identified one usual‐type endocervical adenocarcinoma (0.7%), one endocervical clear cell carcinoma (14.3%), and one endocervical endometroid adenocarcinoma (33.3%) expressing SATB2 [5].